Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBIT Margin (2020 - 2025)

PROCEPT BioRobotics has reported EBIT Margin over the past 6 years, most recently at 40.64% for Q4 2025.

  • Quarterly results put EBIT Margin at 40.64% for Q4 2025, down 1175.0% from a year ago — trailing twelve months through Dec 2025 was 33.71% (up 932.0% YoY), and the annual figure for FY2025 was 33.71%, up 932.0%.
  • EBIT Margin for Q4 2025 was 40.64% at PROCEPT BioRobotics, down from 27.83% in the prior quarter.
  • Over the last five years, EBIT Margin for PRCT hit a ceiling of 27.83% in Q3 2025 and a floor of 166.02% in Q4 2021.
  • Median EBIT Margin over the past 5 years was 75.18% (2023), compared with a mean of 85.45%.
  • Biggest five-year swings in EBIT Margin: surged 37339bps in 2021 and later plummeted -1175bps in 2025.
  • PROCEPT BioRobotics' EBIT Margin stood at 166.02% in 2021, then skyrocketed by 37bps to 105.31% in 2022, then surged by 36bps to 67.82% in 2023, then soared by 57bps to 28.89% in 2024, then plummeted by -41bps to 40.64% in 2025.
  • The last three reported values for EBIT Margin were 40.64% (Q4 2025), 27.83% (Q3 2025), and 28.02% (Q2 2025) per Business Quant data.